Rapid profiling of G2 phase to mitosis progression by flow cytometry in asynchronous cells.


Journal

Cell cycle (Georgetown, Tex.)
ISSN: 1551-4005
Titre abrégé: Cell Cycle
Pays: United States
ID NLM: 101137841

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 13 10 2020
medline: 15 12 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

The precise control of the cell cycle G2 phase to Mitosis (M phase) transition is central for cell fate determination. The commonly used methods for assessing G2 to M phase progression are based on synchronizing cells and involve perturbation of the natural cell cycle progression. Additionally, these methods are often time-consuming and labor-intensive. Here, we report a flow cytometry-based method that offers a kinetic analysis of G2 to M phase progression in asynchronous cells using nocodazole, 5-Ethynyl-2´-deoxyuridine staining, and histone H3 serine 28 phosphorylation (pH3) staining. Nocodazole is used to collect mitotic cells and prevent their progression into G1, at the same time EdU is added for use as a dump channel during analysis. The remaining cells can then be identified as either G1 or G2/M based on their DNA content. Finally, G2 and M phase cells can be separated based on a mitotic marker, phosphorylation of ser28 on histone H3. While developed to assay G2/M phase progression, this method also resolves G1/S phase progression with no additional steps other than analysis. Compared to double thymidine block, this method does not require extended pre-treatments and is compatible with a greater variety of cell lines, while at the same time offering enhanced consistency and temporal resolution.

Identifiants

pubmed: 33043808
doi: 10.1080/15384101.2020.1827510
pmc: PMC7714512
doi:

Substances chimiques

Histones 0
5-ethynyl-2'-deoxyuridine G373S00W2J
Nocodazole SH1WY3R615
Deoxyuridine W78I7AY22C

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2897-2905

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI114581
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA232488
Pays : United States

Références

Exp Cell Res. 1964 Jan;33:301-9
pubmed: 14109144
J Biol Chem. 1999 Sep 3;274(36):25543-9
pubmed: 10464286
Cytometry. 1992;13(7):678-85
pubmed: 1280554
Eur J Biochem. 1978 Mar;84(1):1-15
pubmed: 206429
Exp Cell Res. 1959 Jun;17(3):420-38
pubmed: 13672199
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2415-20
pubmed: 18272492
Science. 1982 Oct 29;218(4571):474-5
pubmed: 7123245
J Vis Exp. 2012 Jan 21;(59):
pubmed: 22297617
J Cell Sci. 1992 Jul;102 ( Pt 3):401-16
pubmed: 1506423
Mol Biol Cell. 1997 Jun;8(6):973-85
pubmed: 9201709
Exp Cell Res. 1995 Apr;217(2):546-53
pubmed: 7698256
Exp Cell Res. 1984 Jun;152(2):459-66
pubmed: 6373328
Mol Cell Biol. 2002 Feb;22(3):874-85
pubmed: 11784863

Auteurs

John Sherman (J)

Center for Childhood Cancer & Blood Diseases, Hematology/Oncology & BMT, The Research Institute at Nationwide Children's Hospital, Ohio State University , Columbus, OH, USA.

Ruoning Wang (R)

Center for Childhood Cancer & Blood Diseases, Hematology/Oncology & BMT, The Research Institute at Nationwide Children's Hospital, Ohio State University , Columbus, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH